Zobrazeno 1 - 10
of 199
pro vyhledávání: '"J Lachmanová"'
Autor:
J, Lachmanová, V, Tesar
Publikováno v:
Vnitrni lekarstvi. 49(5)
Publikováno v:
Casopis lekaru ceskych. 141(8)
Dialysis related amyloidosis (DRA) is a severe complication of the long-term dialysis treatment. beta 2 microglobulin and probably other factors influence the development of amyloid deposits. We investigated some of these factors during hemodialysis
Publikováno v:
Casopis lekaru ceskych. 140(16)
Many hemodialyzed patients complain about bad sleep. The aim of this study was to learn the subjective view of patients on their sleep and its influence by hemodialysis treatment.A simple questionnary containing 20 questions concerning sleep was prep
Autor:
J, Lachmanová
Publikováno v:
Casopis lekaru ceskych. 139(22)
Number of HDS patients has stabilised; however, the technical background of the haemodialysation program is not sufficient, 40% of the dialysation monitors has been amortised. In the dialysed population numbers of elderly patients (60%) and diabetics
Autor:
J, Lachmanová
Publikováno v:
Casopis lekaru ceskych. 138(24)
1. The number of dialyzation centers has not changed during the past two years. Their steep increase occurred in 1990-1995. This development made this treatment available without former limitations (on account of diagnosis and age). 2. In the dialyze
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J, Lachmanová, K, Nĕmecek
Publikováno v:
Casopis lekaru ceskych. 136(13)
1. The number of haemodialyzation centres has more than doubled in the course of five years which increased the dialyzation capacity and at present no patient in the Czech Republic should be denied dialyzation treatment on technical or financial grou
Publikováno v:
Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 52(5)
The author examined 119 patients having regular dialyzation treatment and a control group of 90 healthy subjects, divided into groups by decades. Depending on the intensity of pathological changes, they created four categories; the fifth comprised no
Publikováno v:
Vnitrni lekarstvi. 42(3)
Recombinant erythropoietin (r-HuEPO) was the first growth factor introduced into clinical practice. The main indication for its therapeutic use remains treatment of anaemias during chronic renal failure. In Czech Republic it is at present administere